Pharmacokinetics of Single- and Double-dose Icodextrin
Status:
NOT_YET_RECRUITING
Trial end date:
2025-03-30
Target enrollment:
Participant gender:
Summary
The study aims to provide the pharmacokinetics profiles of single- and double-dose icodextrin in patients on peritoneal dialysis (PD). It may expand the available knowledge of the clinical pharmacology of icodextrin following its intraperitoneal administration and fills the gaps in our understanding of the fate of icodextrin and the metabolic consequences of icodextrin and its metabolites.